2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Gout Flare: new trials by email Literature Review of Gout Flare trials Research Report on Gout Flare
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Tigulixostat, Allopurinol, Placebo - Gout, Hyperuricemia | Phase 3 | Completed | LG Chem | 2202 | 2023-03-30 | 2025-07-22 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack | Phase 2 / Phase 3 | Recruiting | Olatec Therapeutics, Inc. | 300 | 2023-01-06 | 2026-03-11 |
| Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Tigulixostat, Placebo - Gout, Hyperuricemia | Phase 3 | Completed | LG Chem | 354 | 2022-10-25 | 2025-10-29 |
Gout (3) · Hyperuricemia (3) · Arthralgia (1) · Arthritis (1) · Arthritis, Gouty (1) · Inflammation (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Crystal Arthropathies (3) · Genetic Diseases, Inborn (3) · Joint Diseases (3) · Metabolic Diseases (3) · Metabolism, Inborn Errors (3) · Musculoskeletal Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Purine-Pyrimidine Metabolism, Inborn Errors (3) · Rheumatic Diseases (3) · Arthritis (2) · Neurologic Manifestations (1) · Pain (1)
Allopurinol (1) · dapansutrile (1)
LG Chem (2) · Olatec Therapeutics, Inc. (1)
United States (3) · France (2) · Georgia (2) · Philippines (2) · Spain (2) · Thailand (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Colombia (1) · Czechia (1) · Germany (1) · Israel (1)
Hyungjin Cho, MD (2)